<DOC>
	<DOCNO>NCT01438567</DOCNO>
	<brief_summary>The primary research objective demonstrate subject take OXN PR improvement symptom constipation measure Bowel Function Index ( BFI ) compare subject take OxyPR tablet alone cancer non-cancer related pain without reduce effectiveness pain relief measure Brief Pain Inventory ( BPI ) .</brief_summary>
	<brief_title>A Study Demonstrate Improvement Symptoms Constipation Subjects That Require Around-the-clock Opioid Pain Killer Therapy</brief_title>
	<detailed_description>The study OXN3506 multicentre , multiple-dose , randomised , double-blind , double-dummy , active-controlled , parallel-group study male female subject non-malignant malignant pain require opioids ass analgesic efficacy symptom constipation secondary opioid treatment . Subjects randomise two treatment group treat OXN PR OxyPR 5 week . The study compose three phase , pre-randomisation phase , double-blind phase extension phase .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>Inclusion Criteria Subjects receive WHO step III opioid analgesic medication treatment nonmalignant malignant pain . Documented history nonmalignant malignant pain require aroundtheclock opioid therapy Exclusion Criteria Females pregnant lactating . Subjects evidence significant structural abnormality gastrointestinal tract . Subjects evidence impair liver/kidney function upon entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>oxycodone naloxone combination</keyword>
	<keyword>severe chronic non-malignant pain</keyword>
	<keyword>Malignant non-malignant pain require around-the clock opioid therapy</keyword>
	<keyword>Opioid related constipation</keyword>
</DOC>